<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004587A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004587</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13920043</doc-number><date>20130617</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>12</class><subclass>P</subclass><main-group>7</main-group><subgroup>14</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>12</class><subclass>P</subclass><main-group>7</main-group><subgroup>14</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>435162</main-classification></classification-national><invention-title id="d0e43">EGVII ENDOGLUCANASE AND NUCLEIC ACIDS ENCODING THE SAME</invention-title><us-related-documents><division><relation><parent-doc><document-id><country>US</country><doc-number>13286955</doc-number><date>20111101</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8486667</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>13920043</doc-number></document-id></child-doc></relation></division><continuation><relation><parent-doc><document-id><country>US</country><doc-number>12250316</doc-number><date>20081013</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8114655</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>13286955</doc-number></document-id></child-doc></relation></continuation><continuation><relation><parent-doc><document-id><country>US</country><doc-number>11329498</doc-number><date>20060110</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>7449319</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>12250316</doc-number></document-id></child-doc></relation></continuation><division><relation><parent-doc><document-id><country>US</country><doc-number>10028244</doc-number><date>20011218</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>7045331</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>11329498</doc-number></document-id></child-doc></relation></division></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>Danisco US Inc.</orgname><address><city>Palo Alto</city><state>CA</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>DUNN-COLEMAN</last-name><first-name>Nigel</first-name><address><city>El Sauzal</city><country>ES</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>GOEDEGEBUUR</last-name><first-name>Frits</first-name><address><city>Vlaardingen</city><country>NL</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>WARD</last-name><first-name>Michael</first-name><address><city>San Francisco</city><state>CA</state><country>US</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>YAO</last-name><first-name>Jian</first-name><address><city>Sunnyvale</city><state>CA</state><country>US</country></address></addressbook></inventor></inventors></us-parties></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The present invention provides a novel endoglucanase nucleic acid sequence, designated egl7, and the corresponding EGVII amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding EGVII, recombinant EGVII proteins and methods for producing the same.</p></abstract></us-patent-application>